These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2998977)

  • 41. Intravenous hyperimmune globulin prophylaxis against cytomegalovirus interstitial pneumonitis after allogenic bone marrow transplantation.
    Jacobsen N; Schäfer U; Ostendorf P; Kubaneck B; Wolf H
    Tokai J Exp Clin Med; 1985 Jun; 10(2-3):193-5. PubMed ID: 3010510
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of hyperimmune anti-cytomegalovirus immunoglobulins for the prevention of cytomegalovirus infection in recipients of allogeneic bone marrow transplantation: a meta-analysis.
    Messori A; Rampazzo R; Scroccaro G; Martini N
    Bone Marrow Transplant; 1994 Feb; 13(2):163-7. PubMed ID: 8205085
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cyclosporine-steroids versus conventional therapy in cadaver kidney transplantation: analysis of a randomized trial at two years.
    Gianello P; Squifflet JP; Pirson Y; Stoffel M; Dereme T; Alexandre GP
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1867-72. PubMed ID: 3547891
    [No Abstract]   [Full Text] [Related]  

  • 44. Preliminary results of a randomized comparison of cyclosporine and Minnesota Antilymphoblast Globulin.
    Halloran PF; Lien J; Aprile M; White N
    Transplant Proc; 1982 Dec; 14(4):627-30. PubMed ID: 6301117
    [No Abstract]   [Full Text] [Related]  

  • 45. Revisiting the effects of CMV on long-term transplant outcome.
    Baron C; Forconi C; Lebranchu Y
    Curr Opin Organ Transplant; 2010 Aug; 15(4):492-8. PubMed ID: 20631617
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Cytomegalovirus infection after kidney transplantation--importance of the primary infection].
    Castro LA; Schleibner S; Hillebrand G; Land W
    Immun Infekt; 1985 Sep; 13(5):210-4. PubMed ID: 2998976
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.
    Lowance D; Neumayer HH; Legendre CM; Squifflet JP; Kovarik J; Brennan PJ; Norman D; Mendez R; Keating MR; Coggon GL; Crisp A; Lee IC
    N Engl J Med; 1999 May; 340(19):1462-70. PubMed ID: 10320384
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytomegalovirus infection and disease in renal transplant patients treated with cyclosporin. A prospective study.
    Bosch FH; Hoitsma AJ; Janssen HP; van Loon AM; Koene RA
    Transpl Int; 1989 Aug; 2(2):92-5. PubMed ID: 2551314
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cyclosporin A in renal transplantation: a prospective randomized trial.
    Ferguson RM; Rynasiewicz JJ; Sutherland DE; Simmons RL; Najarian JS
    Surgery; 1982 Aug; 92(2):175-82. PubMed ID: 6285533
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preemptive therapy with gancyclovir for early high-risk CMV infection allows effective treatment with antithymocyte globulin of steroid-resistant rejection after renal transplantation.
    van Son WJ; van den Berg AP; The TH; Tegzess AM
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1436-8. PubMed ID: 8382873
    [No Abstract]   [Full Text] [Related]  

  • 51. Mononuclear subsets during cytomegalovirus disease in renal transplant recipients treated with cyclosporine and rabbit antithymocyte globulin.
    Metselaar HJ; Rothbarth PH; Wenting GJ; Vaessen LB; Masurel N; Jeekel J; Weimar W
    J Med Virol; 1986 May; 19(1):95-100. PubMed ID: 3009707
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hyperimmune globulin prophylaxis for cytomegalovirus infection in renal transplantation.
    Wirnsberger GH; Mauric A; Holzer H
    Nephron; 1999; 81(3):368-9. PubMed ID: 10050103
    [No Abstract]   [Full Text] [Related]  

  • 53. Hyperimmune immunoglobulin for cytomegalovirus infections.
    Nicholls AJ; Brown CB; Edward N; Cuthbertson B; Yap PL; McClelland DB
    Lancet; 1983 Mar; 1(8323):532-3. PubMed ID: 6131239
    [No Abstract]   [Full Text] [Related]  

  • 54. Immunoprophylaxis of cytomegalovirus infections in transplanted patients.
    Bron D; Klastersky J
    Eur J Cancer Clin Oncol; 1989 Sep; 25(9):1365-8. PubMed ID: 2553421
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Cytomegalovirus hyperimmunoglobulin prophylaxis following kidney transplantation. Results of a prospective randomized study].
    Grundmann R; Wienand P; Runde A; Baldamus CA; Arns W; Burkhardt U
    Dtsch Med Wochenschr; 1987 May; 112(21):827-31. PubMed ID: 3034541
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fibronectin plasma levels after cadaver kidney transplantation.
    Seitz R; Lutz M; Michalik R; Lange H; Klingemann HG; Egbring R
    Blut; 1985 Jan; 50(1):35-43. PubMed ID: 2981594
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytomegalovirus: the troll of transplantation.
    Balfour HH
    Arch Intern Med; 1979 Mar; 139(3):279-80. PubMed ID: 218511
    [No Abstract]   [Full Text] [Related]  

  • 58. [Is CMV-hyperimmune serum prophylaxis after kidney transplantation always meaningful?].
    Greger B; Kurth J; Schareck WD; Müller GH; Hopt UT; Bockhorn H
    Immun Infekt; 1985 Sep; 13(5):215-9. PubMed ID: 2998977
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anti-CMV hyperimmune globulin prophylaxis does not prevent CMV disease in CMV-negative renal transplant patients.
    Pakkala S; Salmela K; Lautenschlager I; Ahonen J; Häyry P
    Transplant Proc; 1992 Feb; 24(1):283-4. PubMed ID: 1311472
    [No Abstract]   [Full Text] [Related]  

  • 60. Cytomegalovirus hyperimmunoglobulin prophylaxis in the prevention of cytomegalovirus infection in immunosuppressed heart transplant patients.
    Havel M; Teufelsbauer H; Laczkovics A; Kurz R; Wolner E
    Transplant Proc; 1990 Aug; 22(4):1805-6. PubMed ID: 2167533
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.